Authors


Rose Schneider Krivich

Latest:

Anti-seizure drug gets boxed warning for eye damage risks

The FDA has approved changes to the drug label of the anti-seizure drug ezogabine (Potiga), underscoring risks of abnormalities to the retina in the eye, potential vision loss, and skin discoloration-all of which may become permanent.


Michelle Dalton

Latest:

Migraines and retinal perfusion: A headache for physicians, patients

Optical coherence tomography angiography can detect microcirculatory disturbances during acute attacks.


Vanessa Caceres

Latest:

PALADIN subset finds improvement after 12 months with intravitreal implant

Among a subset of patients in the phase IV PALADIN study, there was improved visual acuity, improved macular thickness, and reduced treatment burden among patients treated with the intravitreal fluocinolone acetonide 0.2 µg (Iluvien implant) for DME.


Dr Fahd Quhill

Latest:

Intravitreal implant could bring significant cost savings to NHS England

A study has revealed that a budgetary saving per treated patient with the fluocinolone acetonide implant (Iluvien) versus ranibizumab (Lucentis) could lead to a significant cost-saving to NHS England.


Nicola O'Connell

Latest:

Moorfields research provides hope for choroideremia cure

Preliminary research has shown that ataluren is effective in overriding the nonsense mutation in choroideremia patients, however, further research is needed.


Thomas A. Albini, MD

Latest:

Case #2: Impressions and Clinical Insights

A retina specialist discusses impressions and key take away points from patient case.





David S. Boyer, MD

Latest:

Emerging treatments for advanced dry AMD

Investigational pipeline provides promise for an unmet need.


Dr. Michal S. Nowak

Latest:

Review of the epidemiology of diabetic retinopathy

The prevalence of visual impairment and blindness caused by diabetic retinopathy is increasing worldwide. Early recognition, perhaps via a screening programme, and timely management would be of benefit.


Dr. Andrzej Grzybowski

Latest:

Review of the epidemiology of diabetic retinopathy

The prevalence of visual impairment and blindness caused by diabetic retinopathy is increasing worldwide. Early recognition, perhaps via a screening programme, and timely management would be of benefit.





Malvika Arya, BS

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


A. Yasin Alibhai, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Carl B. Rebhun, BA

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Xuejing Chen, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Elias Reichel, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Caroline R. Baumal, MD

Latest:

Take-Home Points for the Treatment of AMD and DME

David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.


Andre J. Witkin, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Jay S. Duker, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Nadia K. Waheed, MD, MPH

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability






Netan Choudhry, MD

Latest:

The subthreshold laser’s role in retinal vascular disease

Combination therapy benefits from laser in the mix for DME, other conditions


Munir Escaf, MD

Latest:

Laser therapy may offer fast-acting option for CSR resolution

Patients tolerate therapy well; high safety profile allows re-treatment as necessary

© 2025 MJH Life Sciences

All rights reserved.